Skip to content
Kaléo Medical Affairs Logo
  • PUBLICATIONS
  • RESOURCES FOR HCPs
  • RESOURCES FOR PATIENTS AND CAREGIVERS
  • NEWS & EVENTS
Kaléo Medical Affairs Logo
  • PUBLICATIONS
  • RESOURCES FOR HCPs
  • RESOURCES FOR PATIENTS AND CAREGIVERS
  • NEWS & EVENTS
Healthcare Costs Associated With Patients Experiencing Mild-to-Moderate or Severe Anaphylaxis Prescribed Auvi-Q vs. Other Epinephrine Auto-Injectors in a U.S. Commercial Claims Database Study
By scott@zimmerdesignstudio.com|2026-02-11T04:40:25+00:00January 30, 2026|Comments Off on Healthcare Costs Associated With Patients Experiencing Mild-to-Moderate or Severe Anaphylaxis Prescribed Auvi-Q vs. Other Epinephrine Auto-Injectors in a U.S. Commercial Claims Database Study

Can’t find what you’re looking for?

Contact Us
Frequently Asked Questions

Disclaimer | Kaléo Corporate | © 2026 kaleo, Inc. | MED-US-0121 | All Rights Reserved.

Can’t find what you’re looking for?

Contact Us
Frequently Asked Questions

Disclaimer | Kaléo Corporate | © 2026 kaleo, Inc. | MED-US-0121 | All Rights Reserved.

Page load link

Welcome

The information on this site is for U.S. Healthcare Professionals only. Click “Proceed” only if you are a U.S. Healthcare Professional.

Proceed
×

You are leaving kaleomedicalaffairs.com

Kaléo is not responsible for the way information is processed by sites linked to this one. Please review those sites' privacy policies and terms of use to understand how your information will be processed. Link to any other site at your own risk.

Proceed
Kaléo Medical Affairs
Powered by  GDPR Cookie Compliance (opens in a new tab)

Privacy Overview

More information about our Privacy & Cookie Policy

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
Go to Top